$THLD new volume recovery $1.21 Website

New Post Public Reply Private Reply Replies (1) Message Board
PoemStone
$THLD new volume recovery $1.21

Website
threshold.png


Shares Outstanding 71.51M
Float 65.4M

% Held by Insiders 10.38%
% Held by Institutions 1 52.40%
Shares Short 292.39k
Short Ratio 0.49
Short % of Float 0.44%
Shares Short (prior month) 413.1k

Headlines
and Filings

Threshold Pharmaceuticals, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic agents that target tumor cells for the treatment of patients living with cancer in the United States. Its lead investigational small molecule is evofosfamide, which is in two Phase III clinical trials for the treatment of soft tissue sarcoma indication and advanced pancreatic cancer; Phase II clinical trials for treating non-squamous non-small cell lung cancer; Phase II clinical trials for advanced melanoma; and Phase I/II clinical trials for multiple myeloma. The company is also involved in the study of evofosfamide in investigator sponsored trials, including Phase I/II clinical trials for glioblastoma; Phase I clinical trials for advanced renal cell carcinoma, gastrointestinal stromal tumors, and pancreatic neuroendocrine tumors; Phase II clinical trials for glioblastoma and pancreatic neuroendocrine tumors; Phase I clinical trials for advanced solid tumors; and Phase I/II clinical trials for advanced kidney cancer or liver cancer. In addition, it engages in developing Tarloxotinib, an investigational hypoxia-activated EGFR tyrosine kinase inhibitor, which is in two Phase II clinical trials for patients with advanced non-squamous non-small cell lung cancer, as well as patients with squamous cell carcinomas of the head, neck, or skin; and [18F]-HX4, an investigational PET imaging agent for hypoxia. The company has a license and co-development agreement with Merck KGaA to co-develop and commercialize evofosfamide; license agreement with Auckland UniServices Ltd. for the development program based on Tarloxotinib; and license agreement with Eleison Pharmaceuticals, Inc. for the manufacture, development, and commercialization of glufosfamide for the treatment of cancer in humans and animals, as well as other uses. Threshold Pharmaceuticals, Inc. was founded in 2001 and is headquartered in South San Francisco, California.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hisense and UEFA 2028: A Winning Partnership Experience

Updated Category News Views 3

Hisense Extends its UEFA Adventure You ever get the feeling that some partnerships are like a football match made in heaven? Well, Hisense surely seems to think so as they've renewed their gig with UEFA for the 2028 European Championship. That's their fourth tango with UEFA, a relationship that's matured like a fine wine since it all kicked off in 2016. Now, if you're...

Continue Reading
Innovation Drives New Asia-Pacific Opportunities

Updated Category News Views 1

A Glimpse Into The Future: Asia-Pacific's Tech Landscape There's a unique transformation bubbling across the Asia-Pacific scene, with young minds pushing the envelope on technology and innovation. Take Nathapol's team from Thailand, for example. They're merging bionic tech with drones for disaster relief—bold, ambitious, and nearly clinching glory at the Lancang-Mekong...

Continue Reading
USF Law Innovators: Leading AI Integration in Academics

Updated Category News Views 2

Revolutionizing Legal Academia with AI If there's one thing that's caught my eye in the realm of education, it's how some folks over at the University of San Francisco School of Law are shaking things up. These legal eagles aren't messing around with the usual, archaic ways of teaching the law. Nope, they've dove headfirst into the future by hooking their curriculum to...

Continue Reading
University of Phoenix Boosts Networking Strategies

Updated Category News Views 1

Building Networks: A Key to Professional Growth Listen up, because everyone and their dog is gabbing about mentorship and networking these days—and for good reason. The University of Phoenix is cracking this nut open with their latest webinar, "Build the Network That Advances Your Career: Mentors, Peers & Community," happening on September 17th. They're not just...

Continue Reading
PROCEPT Faces Legal Storm Over Sales Practices Missteps

Updated Category News Views 1

Investors Take Aim: A Legal Showdown on the Horizon There's a brewing storm over at PROCEPT BioRobotics—ticker NASDAQ:PRCT if you're tracking. These folks are knee-deep in a securities class action lawsuit from investors who’ve taken a financial wallop. The lawsuits are triggered by allegations of shady sales techniques that artificially bumped up their unit sales...

Continue Reading
TECNO Unleashes New Laptops & Phones at IFA 2026

Updated Category News Views 2

A Bold Leap by TECNO You walk into the IFA ShowStoppers 2026 event, and what’s greeting you is a flashy splash of next-gen tech from TECNO. Now, if you thought this brand was only about pushing phones, you're in for a ride. TECNO has crashed the laptop party with its new MEGABOOK T15 360 Series, showing it’s more than capable of straddling the tablet and laptop worlds...

Continue Reading
Reolink Unveils OMVI 2i Ultra at IFA 2026

Updated Category News Views 2

Reolink's Bold Move Into the Future of Home Security Amidst the hustle of Berlin's IFA 2026, Reolink dropped its latest gem: the OMVI 2i Ultra—an all-in-one security powerhouse promising to change the game for home protection junkies. As usual, Reolink's got its eyes on the prize, pushing boundaries with this latest lineup. OMVI 2i Ultra: Dual-View Revolution If you've...

Continue Reading
Doug Larson Takes Helm at Integra Pool Covers

Updated Category News Views 2

A Seasoned Pro Joins Integra Pool Covers Change is afoot over at Explore Industries. They just tapped Doug Larson to be the General Manager for their Integra Pool Covers division. Now, I've seen plenty of hiring announcements in my day, but this has got an interesting ring to it. With Doug on this ship, it's like bringing a wolf back to the wild. Larson's no stranger to...

Continue Reading
Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

Updated Category News Views 2

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

Continue Reading
PlugClaw: TrustKernel's AI Gadget Tackles Privacy Hurdles

Updated Category News Views 2

A Handy Revolution in AI Computing You know, every now and then, a gadget shows up that flips the scene on its head. Enter TrustKernel's PlugClaw. It's not every day you see a whole computer in something barely the size of your thumb, yet this one does exactly that. Weighing in at a measly 15 grams and armed with a MediaTek Helio G80, we're looking at a USB-C stick that's...

Continue Reading

Top 5 Most Recently Viewed Articles

Snowflake's Options Activity: Insights from Recent Trends

Updated Category News Views 64

Understanding the Options Activity Surge in Snowflake Investors are making significant moves regarding Snowflake (NASDAQ: SNOW), signaling noteworthy trends that retail traders should pay close attention to. Recently, data from options trading has revealed a substantial uptick in activity, which appears to be driven by major investors with considerable capital. The...

Continue Reading
Stingray Expands Digital Horizons with Loupe Art Acquisition

Updated Category News Views 213

Stingray's Strategic Acquisition of Loupe Art Stingray, recognized for its leadership in music and video content distribution, has made a significant move by acquiring Loupe Art. This acquisition focuses on bolstering Stingray's offerings in the Connected TV and digital signage arenas, further solidifying its reputation in the digital media landscape. Enhanced Offerings...

Continue Reading
Rivian's Federal Loan Under Review Amid Key Changes in Management

Updated Category News Views 296

Rivian Automotive's $6.6 Billion Loan Faces Uncertainty Rivian Automotive Inc.'s funding for its ambitious electric vehicle manufacturing plant has entered a precarious phase. The company's $6.6 billion federal loan, pivotal for its operations, is currently under review due to actions led by the previous administration. The Current Situation Insights from Georgia's...

Continue Reading
Cutting Tool Inserts Market Growth Driven by Additive Manufacturing

Updated Category News Views 62

Cutting Tool Inserts Market Growth Driven by Additive Manufacturing The Global Cutting Tool Inserts Market is poised for substantial growth, with expectations of increasing by USD 2.12 billion within a designated period. This remarkable growth reflects a compound annual growth rate (CAGR) of over 5.8%, a trajectory powered significantly by advancements in artificial...

Continue Reading
ORR Protection Welcomes New CEO Woodie Andrawos Amid Growth

Updated Category News Views 301

Woodie Andrawos Appointed as Chief Executive Officer of ORR Protection ORR Protection has taken a significant step forward in its evolution by appointing Woodie Andrawos as the new Chief Executive Officer. He succeeds Ray Aldridge, who has served the company with dedication for over three decades. This leadership change marks a pivotal moment, reflecting ORR's commitment...

Continue Reading